
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $337.5M | $490.1M | $620.7M | $675.4M | $698.8M | |
Revenue Growth (YoY) | 39.39% | 45.22% | 26.65% | 8.8% | 3.46% | |
Cost of Revenues | $115M | $162.2M | $217.4M | $231M | $228.4M | |
Gross Profit | $222.5M | $327.9M | $403.4M | $444.4M | $470.4M | |
Gross Profit Margin | 65.92% | 66.9% | 64.98% | 65.8% | 67.32% | |
R&D Expenses | $30.4M | $49.5M | $71.6M | $75.6M | $79.7M | |
Selling, General & Admin | $137.3M | $204.2M | $251.5M | $255.8M | $261.9M | |
Other Inc / (Exp) | -- | -$28.7M | -- | -$6.3M | -$39.7M | |
Operating Expenses | $244.5M | $355.1M | $434M | $435.6M | $430.4M | |
Operating Income | -$22M | -$27.2M | -$30.6M | $8.8M | $40M | |
Net Interest Expenses | $41.5M | $36.1M | $33.9M | $46.4M | $35.6M | |
EBT. Incl. Unusual Items | -$63.6M | -$92M | -$64.5M | -$44M | -$35.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$3.6M | -$10.1M | -$4.7M | $1.6M | $5.8M | |
Net Income to Company | -$60M | -$82M | -$59.8M | -$45.6M | -$41.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$60M | -$82M | -$59.8M | -$45.6M | -$41.1M | |
Basic EPS (Cont. Ops) | -$2.94 | -$0.82 | -$0.31 | -$0.24 | -$0.22 | |
Diluted EPS (Cont. Ops) | -$2.94 | -$0.82 | -$0.31 | -$0.24 | -$0.22 | |
Weighted Average Basic Share | $43.5M | $117.8M | $194.6M | $188.9M | $184.9M | |
Weighted Average Diluted Share | $43.5M | $117.8M | $194.6M | $188.9M | $184.9M | |
EBITDA | $54.8M | $45.5M | $80.2M | $106.6M | $89.1M | |
EBIT | -$22M | -$55.9M | -$30.6M | $2.4M | $252K | |
Revenue (Reported) | $337.5M | $490.1M | $620.7M | $675.4M | $698.8M | |
Operating Income (Reported) | -$22M | -$27.2M | -$30.6M | $8.8M | $40M | |
Operating Income (Adjusted) | -$22M | -$55.9M | -$30.6M | $2.4M | $252K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $104.9M | $143.6M | $161.1M | $137.9M | $142.3M | |
Revenue Growth (YoY) | 36.2% | 36.86% | 12.23% | -14.45% | 3.21% | |
Cost of Revenues | $35.7M | $50.7M | $55.9M | $31.5M | $31.2M | |
Gross Profit | $69.2M | $92.8M | $105.2M | $106.4M | $111.1M | |
Gross Profit Margin | 65.99% | 64.66% | 65.28% | 77.15% | 78.08% | |
R&D Expenses | $10.3M | $17.6M | $18.7M | $19.3M | $20M | |
Selling, General & Admin | $41.8M | $61.4M | $64.8M | $59.2M | $60.1M | |
Other Inc / (Exp) | -- | -- | -$1.1M | -$11.2M | -$85K | |
Operating Expenses | $75.8M | $106.4M | $109.4M | $99.4M | $96.8M | |
Operating Income | -$6.6M | -$13.6M | -$4.2M | $6.9M | $14.3M | |
Net Interest Expenses | $12.9M | $5.5M | $15.2M | $5.8M | $12.8M | |
EBT. Incl. Unusual Items | -$19.5M | -$19M | -$20.5M | -$10.1M | $1.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -$314K | -$8.6M | |
Income Tax Expense | -$3.5M | -$5.7M | $299K | $5.9M | $512K | |
Net Income to Company | -$16M | -$13.3M | -$20.8M | -$16.3M | -$7.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$16M | -$13.3M | -$20.8M | -$16.3M | -$7.7M | |
Basic EPS (Cont. Ops) | -$0.16 | -$0.07 | -$0.11 | -$0.09 | -$0.04 | |
Diluted EPS (Cont. Ops) | -$0.16 | -$0.07 | -$0.11 | -$0.09 | -$0.04 | |
Weighted Average Basic Share | $192.5M | $195.4M | $190M | $186.6M | $183.5M | |
Weighted Average Diluted Share | $192.5M | $195.4M | $190M | $186.6M | $185.2M | |
EBITDA | $17.1M | $13.8M | $20.7M | $18.7M | $32.2M | |
EBIT | -$6.6M | -$13.6M | -$5.3M | -$4.3M | $14.2M | |
Revenue (Reported) | $104.9M | $143.6M | $161.1M | $137.9M | $142.3M | |
Operating Income (Reported) | -$6.6M | -$13.6M | -$4.2M | $6.9M | $14.3M | |
Operating Income (Adjusted) | -$6.6M | -$13.6M | -$5.3M | -$4.3M | $14.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $365.4M | $528.8M | $638.3M | $652.1M | $670.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $122.9M | $177.3M | $222.6M | $206.6M | $202.8M | |
Gross Profit | $242.5M | $351.5M | $415.7M | $445.5M | $468.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $32.3M | $56.8M | $72.7M | $76.2M | $79.4M | |
Selling, General & Admin | $144.8M | $223.7M | $254.9M | $250.2M | $258.4M | |
Other Inc / (Exp) | -- | -$28.7M | -$1.1M | -$16.5M | -$28.6M | |
Operating Expenses | $260.8M | $385.7M | $437M | $425.6M | $420.5M | |
Operating Income | -$18.3M | -$34.2M | -$21.3M | $19.9M | $47.6M | |
Net Interest Expenses | $43.7M | $28.6M | $43.6M | $37M | $42.5M | |
EBT. Incl. Unusual Items | -$62M | -$91.5M | -$65.9M | -$33.6M | -$23.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -$314K | -$8.6M | |
Income Tax Expense | -$6M | -$12.3M | $1.4M | $7.3M | $371K | |
Net Income to Company | -$56M | -$79.3M | -$67.3M | -$41.2M | -$32.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$56M | -$79.3M | -$67.3M | -$41.2M | -$32.5M | |
Basic EPS (Cont. Ops) | -$2.33 | -$0.42 | -$0.35 | -$0.22 | -$0.18 | |
Diluted EPS (Cont. Ops) | -$2.33 | -$0.42 | -$0.35 | -$0.22 | -$0.18 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $65.4M | $42.2M | $87M | $104.6M | $102.9M | |
EBIT | -$18.3M | -$62.9M | -$22.3M | $3.4M | $19.1M | |
Revenue (Reported) | $365.4M | $528.8M | $638.3M | $652.1M | $670.9M | |
Operating Income (Reported) | -$18.3M | -$34.2M | -$21.3M | $19.9M | $47.6M | |
Operating Income (Adjusted) | -$18.3M | -$62.9M | -$22.3M | $3.4M | $19.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $104.9M | $143.6M | $161.1M | $137.9M | $142.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $35.7M | $50.7M | $55.9M | $31.5M | $31.2M | |
Gross Profit | $69.2M | $92.8M | $105.2M | $106.4M | $111.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $10.3M | $17.6M | $18.7M | $19.3M | $20M | |
Selling, General & Admin | $41.8M | $61.4M | $64.8M | $59.2M | $60.1M | |
Other Inc / (Exp) | -- | -- | -$1.1M | -$11.2M | -$85K | |
Operating Expenses | $75.8M | $106.4M | $109.4M | $99.4M | $96.8M | |
Operating Income | -$6.6M | -$13.6M | -$4.2M | $6.9M | $14.3M | |
Net Interest Expenses | $12.9M | $5.5M | $15.2M | $5.8M | $12.8M | |
EBT. Incl. Unusual Items | -$19.5M | -$19M | -$20.5M | -$10.1M | $1.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -$314K | -$8.6M | |
Income Tax Expense | -$3.5M | -$5.7M | $299K | $5.9M | $512K | |
Net Income to Company | -$16M | -$13.3M | -$20.8M | -$16.3M | -$7.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$16M | -$13.3M | -$20.8M | -$16.3M | -$7.7M | |
Basic EPS (Cont. Ops) | -$0.16 | -$0.07 | -$0.11 | -$0.09 | -$0.04 | |
Diluted EPS (Cont. Ops) | -$0.16 | -$0.07 | -$0.11 | -$0.09 | -$0.04 | |
Weighted Average Basic Share | $192.5M | $195.4M | $190M | $186.6M | $183.5M | |
Weighted Average Diluted Share | $192.5M | $195.4M | $190M | $186.6M | $185.2M | |
EBITDA | $17.1M | $13.8M | $20.7M | $18.7M | $32.2M | |
EBIT | -$6.6M | -$13.6M | -$5.3M | -$4.3M | $14.2M | |
Revenue (Reported) | $104.9M | $143.6M | $161.1M | $137.9M | $142.3M | |
Operating Income (Reported) | -$6.6M | -$13.6M | -$4.2M | $6.9M | $14.3M | |
Operating Income (Adjusted) | -$6.6M | -$13.6M | -$5.3M | -$4.3M | $14.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $96M | $94M | $92.6M | $92.6M | $135.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $25M | $40.5M | $48M | $45.4M | $40.2M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $10.7M | $22.5M | $23.8M | $22.4M | $29.1M | |
Total Current Assets | $143.8M | $171.6M | $180.6M | $180.1M | $218.3M | |
Property Plant And Equipment | $14.7M | $13.5M | $11.9M | $9.7M | $6.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $668.2M | $921.4M | $914.1M | $927.4M | $886.3M | |
Other Intangibles | $486.8M | $532.5M | $438.3M | $358M | $270.5M | |
Other Long-Term Assets | $14.1M | $24.3M | $46.9M | $42.7M | $39.5M | |
Total Assets | $1.3B | $1.7B | $1.6B | $1.5B | $1.4B | |
Accounts Payable | $11.1M | $10.3M | $8.4M | $8.6M | $8M | |
Accrued Expenses | $46.4M | $49.3M | $57M | $66.3M | $58.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $86.7M | $103.4M | $105.1M | $117.4M | $110.7M | |
Long-Term Debt | $691M | $535.2M | $530.9M | $526.7M | $522.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $808.4M | $677.7M | $685M | $692M | $670.4M | |
Common Stock | $908.3M | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | $1.5M | -$1.8M | -$10.2M | -$8M | -$14.3M | |
Common Equity | -$389.2M | $985.6M | $906.7M | $826M | $750.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $519.2M | $985.6M | $906.7M | $826M | $750.8M | |
Total Liabilities and Equity | $1.3B | $1.7B | $1.6B | $1.5B | $1.4B | |
Cash and Short Terms | $96M | $94M | $92.6M | $92.6M | $135.8M | |
Total Debt | $698.3M | $546.1M | $536.4M | $532.2M | $527.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $87M | $101.2M | $69.8M | $90M | $148.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $29.3M | $42.3M | $48M | $48.4M | $32.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $11.8M | $26.3M | $27.2M | $27.7M | $30.2M | |
Total Current Assets | $138.9M | $186.5M | $163.3M | $194.6M | $268.5M | |
Property Plant And Equipment | $14.1M | $13.4M | $11.4M | $8.3M | $5.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $719.4M | $921.6M | $913.8M | $917.7M | $863.7M | |
Other Intangibles | $488.7M | $508.9M | $417.6M | $322.2M | $241.1M | |
Other Long-Term Assets | $16.3M | $21M | $44.5M | $39.7M | $34.9M | |
Total Assets | $1.4B | $1.7B | $1.6B | $1.5B | $1.4B | |
Accounts Payable | $12.7M | $8.2M | $8.1M | $8.1M | $7.5M | |
Accrued Expenses | $36.5M | $53.7M | $57.1M | $57.8M | $54.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $5.5M | $5.5M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | $5.8M | $15.6M | |
Total Current Liabilities | $83.1M | $108.9M | $105.3M | $113.9M | $117.5M | |
Long-Term Debt | $758.4M | $534.1M | $529.9M | $525.6M | $521.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $871.6M | $672.9M | $687.6M | $681.8M | $674.5M | |
Common Stock | $923.4M | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | $2.1M | -$2.4M | -$10.3M | -$11.6M | -$13.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $505.8M | $978.5M | $863M | $800.7M | $739.6M | |
Total Liabilities and Equity | $1.4B | $1.7B | $1.6B | $1.5B | $1.4B | |
Cash and Short Terms | $87M | $101.2M | $69.8M | $90M | $148.4M | |
Total Debt | $766.4M | $545.2M | $535.4M | $531.1M | $526.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$60M | -$82M | -$59.8M | -$45.6M | -$41.1M | |
Depreciation & Amoritzation | $76.8M | $101.4M | $110.8M | $104.2M | $88.8M | |
Stock-Based Compensation | $10.7M | $22.1M | $26.8M | $25.6M | $26.5M | |
Change in Accounts Receivable | -$516K | -$13.3M | -$13.2M | -$5M | -$319K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $57.5M | $37.5M | $64.8M | $104.6M | $113.2M | |
Capital Expenditures | $13.1M | $14.8M | $18.1M | $23.1M | $18.9M | |
Cash Acquisitions | -$403.2M | -$364.9M | -- | -$14.9M | $6.6M | |
Cash From Investing | -$418.3M | -$379.7M | -$18.1M | -$38M | -$12.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $314.7M | $851M | -- | -- | -- | |
Long-Term Debt Repaid | -$55.9M | -$1B | -$9.5M | -$5.5M | -$5.5M | |
Repurchase of Common Stock | -- | -- | -$43M | -$67.3M | -$57.7M | |
Other Financing Activities | -$7.3M | -$8.1M | -- | -- | -$3.8M | |
Cash From Financing | $401.9M | $341.2M | -$47.3M | -$66.6M | -$59.6M | |
Beginning Cash (CF) | $57.3M | $98.3M | $97.6M | $95.8M | $96.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $41.1M | -$1M | -$587K | -$45K | $41.3M | |
Ending Cash (CF) | $98.3M | $97.6M | $95.8M | $96.2M | $135.8M | |
Levered Free Cash Flow | $44.5M | $22.7M | $46.7M | $81.5M | $94.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$16M | -$13.3M | -$20.8M | -$16.3M | -$7.7M | |
Depreciation & Amoritzation | $23.7M | $27.4M | $26M | $23M | $18M | |
Stock-Based Compensation | $903K | $6.1M | $7.5M | $5.6M | $6.9M | |
Change in Accounts Receivable | -$4.7M | -$2.3M | -$2.6M | -$4.5M | -$3.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$5.4M | $12.9M | $12.7M | $13.3M | $30.7M | |
Capital Expenditures | $3M | $4.4M | $4.9M | $4.8M | $5.6M | |
Cash Acquisitions | -$69.1M | -- | -- | $1.2M | -$85K | |
Cash From Investing | -$72.1M | -$4.4M | -$4.9M | -$3.6M | -$5.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $69.2M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$2M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | |
Repurchase of Common Stock | -- | -- | -$29.6M | -$12.1M | -$11.1M | |
Other Financing Activities | -- | -- | -- | -- | -$1.2M | |
Cash From Financing | $67.9M | -$652K | -$30.4M | -$12.4M | -$12.3M | |
Beginning Cash (CF) | $98.3M | $97.6M | $95.8M | $96.2M | $135.8M | |
Foreign Exchange Rate Adjustment | $196K | -$370K | $50K | -$593K | -$142K | |
Additions / Reductions | -$9.6M | $7.8M | -$22.6M | -$2.7M | $12.8M | |
Ending Cash (CF) | $88.9M | $105M | $73.3M | $92.9M | $148.4M | |
Levered Free Cash Flow | -$8.4M | $8.5M | $7.8M | $8.5M | $25.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$56M | -$79.3M | -$67.3M | -$41.2M | -$32.5M | |
Depreciation & Amoritzation | $83.7M | $105.1M | $109.4M | $101.2M | $83.8M | |
Stock-Based Compensation | $10.8M | $27.3M | $28.2M | $23.6M | $27.9M | |
Change in Accounts Receivable | -$3.6M | -$10.9M | -$13.6M | -$6.9M | $1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $55.5M | $55.7M | $64.6M | $105.2M | $130.5M | |
Capital Expenditures | $10.9M | $16.2M | $18.5M | $23.1M | $19.6M | |
Cash Acquisitions | -$403.5M | -$295.8M | -- | -$13.7M | $5.3M | |
Cash From Investing | -$416.5M | -$311.9M | -$18.5M | -$36.8M | -$14.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $282.8M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$56.6M | -$1B | -$9.5M | -$5.5M | -$5.5M | |
Repurchase of Common Stock | -- | -- | -$72.6M | -$49.7M | -$56.7M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $370M | $272.6M | -$77.1M | -$48.6M | -$59.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $9M | $16.4M | -$31M | $19.8M | $56.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $44.6M | $39.6M | $46.1M | $82.1M | $110.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$16M | -$13.3M | -$20.8M | -$16.3M | -$7.7M | |
Depreciation & Amoritzation | $23.7M | $27.4M | $26M | $23M | $18M | |
Stock-Based Compensation | $903K | $6.1M | $7.5M | $5.6M | $6.9M | |
Change in Accounts Receivable | -$4.7M | -$2.3M | -$2.6M | -$4.5M | -$3.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$5.4M | $12.9M | $12.7M | $13.3M | $30.7M | |
Capital Expenditures | $3M | $4.4M | $4.9M | $4.8M | $5.6M | |
Cash Acquisitions | -$69.1M | -- | -- | $1.2M | -$85K | |
Cash From Investing | -$72.1M | -$4.4M | -$4.9M | -$3.6M | -$5.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $69.2M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$2M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | |
Repurchase of Common Stock | -- | -- | -$29.6M | -$12.1M | -$11.1M | |
Other Financing Activities | -- | -- | -- | -- | -$1.2M | |
Cash From Financing | $67.9M | -$652K | -$30.4M | -$12.4M | -$12.3M | |
Beginning Cash (CF) | $98.3M | $97.6M | $95.8M | $96.2M | $135.8M | |
Foreign Exchange Rate Adjustment | $196K | -$370K | $50K | -$593K | -$142K | |
Additions / Reductions | -$9.6M | $7.8M | -$22.6M | -$2.7M | $12.8M | |
Ending Cash (CF) | $88.9M | $105M | $73.3M | $92.9M | $148.4M | |
Levered Free Cash Flow | -$8.4M | $8.5M | $7.8M | $8.5M | $25.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.